News Search Results
Jan 16, 2025, 09:32 ET Kadimastem Calls for a Special General Meeting of Shareholders to Approve the Merger with NLS
October 2024, lays the groundwork for facilitating the proposed merger with NLS, which aims to create a combined Nasdaq-traded biotechnology company with a robust pipeline of advanced therapies. Additionally, NLS has recently filed F-4 Registration Statement on Form F-4 with the
More news about: Kadimastem Ltd.; NLS Pharmaceutics Ltd.
Jan 16, 2025, 09:28 ET REGN INVESTOR NOTICE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
e-mail at [email protected]. CASE ALLEGATIONS: Regeneron is a biotechnology company that designs products for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, among others.
More news about: Robbins Geller Rudman & Dowd LLP
Jan 16, 2025, 08:59 ET Origin Agritech Showcases Advanced Biotechnology Capabilities and Announces Landmark Partnership at International Seed Industry Conference
2024Establishing the "Origin Marker Biological Breeding Service Consortium" with China Golden Marker Biotechnology Co., Ltd. and launching four comprehensive biotechnology services: BBL2-2 transgenic applications, molecular marker and variety improvement, gene editing trait improvement,
More news about: Origin Agritech Limited
Jan 16, 2025, 08:30 ET Switch Bioworks Awarded $2M in Federal Funding for Technology to Reduce Synthetic Nitrogen Fertilizer in Crop Production
SAN FRANCISCO, Jan. 16, 2025 /PRNewswire/ -- Switch Bioworks, a biotechnology company developing low-cost and sustainable fertilizers, has been awarded a $2 million grant from the U.S. Department
More news about: Switch Bioworks
Jan 16, 2025, 08:30 ET Emmes Group® names Germaine Gross Chief Commercial Officer of Emmes® Biopharma
Emmes has supported more than 2,000 clinical trials across numerous agencies and institutes of the U.S. federal government and a wide range of biotechnology, pharmaceutical and medical device companies throughout the world. The company has built industry leading capabilities in cell and gene therapy,
More news about: Emmes
Jan 16, 2025, 08:28 ET Integral Molecular Recognized as an Employer of Choice by the City of Philadelphia
PHILADELPHIA, Jan. 16, 2025 /PRNewswire/ -- Integral Molecular, a leading biotechnology company in Philadelphia, is honored to announce its recognition as an Employer of Choice by the City
More news about: Integral Molecular
Jan 16, 2025, 07:30 ET Soligenix to Present at Upcoming Investor Conferences
procurement contracts with the U.S. Government or other countries, that it will be able to compete with larger and better financed competitors in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives will
More news about: SOLIGENIX, INC.
Jan 16, 2025, 07:00 ET MediPharm Labs Provides Update on Previously Announced Sale of Napanee Facility to Kensana Health
2024. About Kensana Health Kensana Health is a Canadian private company with global operations. Kensana Health is a unique hybrid biotechnology company with an experienced team within the pharmaceutical industry, including world renowned experts in plant-based medicines, as well as chronic
More news about: MediPharm Labs Corp.
Jan 16, 2025, 07:00 ET BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a market projected to grow to USD$48,000,000,000 by 2030*
receive the required regulatory approvals. With regards to BioVaxys' business, there are a number of risks that could affect the development of its biotechnology products, including, without limitation, the need for additional capital to fund clinical trials, its lack of operating history, uncertainty about
More news about: BioVaxys Technology Corp.
Jan 16, 2025, 03:09 ET Amino Acid Fertilizer Market to Boost Revenue by USD 392.4 Million from 2025-2029 with Global Agricultural Initiatives - Report on How AI is Redefining the Market Landscape - Technavio
forms, are essential components of sustainable food systems, contributing to food security and crop yield enhancement. Agricultural innovation and biotechnology play a crucial role in the development of eco-friendly amino acid fertilizers, promoting water-efficient farming and reducing greenhouse gas emissions.
More news about: Technavio
Jan 16, 2025, 02:00 ET Campus Kalundborg announces DKK 320m expansion plan to become a leading hub for education, research and innovation within biomanufacturing and biosolutions
A specialisation in pharma and food ingredients on the vocational process operator programme at NEG Kalundborg (in Danish) 2017: BEng in Biotechnology at University College Absalon (in Danish and in English) 2018: Bachelor of Biomedical Laboratory Science at University College Absalon (in
More news about: Campus Kalundborg
Jan 16, 2025, 00:31 ET CrisprBits opens Research and Innovation Centre for CRISPR Gene Editing and Diagnostics in Bengaluru
India, Jan. 16, 2025 /PRNewswire/ -- Bengaluru-based biotechnology startup, CrisprBits Private Limited, has inaugurated a CRISPR gene editing and diagnostics laboratory in Bengaluru.
More news about: CrisprBits
Jan 15, 2025, 20:00 ET (Taiwan) CMU Healthcare System and Nobel Laureate Randy Schekman Drive New Frontiers in Exosome Technology
Translational Medicine Research Center showcased dual-gene-engineered exosomes for improving neurological recovery after stroke. Partnering with Shine-Out BioTechnology Co., CMUH developed targeted exosome platforms for treating neurodegenerative diseases like Parkinson's and Alzheimer's. These platforms are designed
More news about: China Medical University Hospital
Jan 15, 2025, 16:06 ET FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Jan 15, 2025, 10:14 ET Dynarex Launches LabChoice: Precision Tools for Today's Laboratories
control.Cell Culture and Molecular Biology: Petri dishes, cryogenic tubes, and inoculation loops support key workflows in academic research, biotechnology, and clinical laboratories.Mixing and Centrifugation: Centrifuge tubes and reversible tube racks streamline sample preparation processes,
More news about: Dynarex Corporation
Jan 15, 2025, 10:10 ET Cutting-Edge Cancer Therapies Lead the Way into a Transformative Year
industry developments and happenings in the market include: Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, NeoGenomics,
More news about: USA News Group
Jan 15, 2025, 09:10 ET Biotechnology Company Psilera Convenes Prominent Industry Leaders & Patient Advocates for First FTD Research Summit
Fla., Jan. 15, 2025 /PRNewswire/ -- Psilera, Inc. (Psilera), a biotechnology research company specializing in the development of novel therapeutic compounds for the treatment of rare and neurological diseases, is hosting
More news about: Psilera
Jan 15, 2025, 09:00 ET Axcynsis Therapeutics Receives FDA Clearance for IND Application of AT03-65, a Differentiated CLDN6-Targeting ADC, Powered by AxcynDOT™ Technology
improved safety profile compared to trabectedin. About Axcynsis Therapeutics Axcynsis Therapeutics is a pioneering biotechnology company headquartered in Singapore with operations in the United States. The company
More news about: Axcynsis Therapeutics Pte Ltd
Jan 15, 2025, 08:30 ET TCBP Announces H5N1 Proof of Concept Studies Intention
Jan. 15, 2025 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that it intends to begin Proof
More news about: TC BioPharm
Jan 15, 2025, 08:19 ET Robles BioCeutics Presents Glowselle™ Stem Cell Powered Cosmetic Data at Biotech Showcase 2025
Graft, CEO of Leonhardt Ventures and Advisory Board Member of the Company. "Being chosen to present at the premier event for private and mid-cap biotechnology companies is testimony to the positive responses the company's approach is receiving from the industry." Glowselle, the Company's flagship
More news about: Robles BioCeutics
Jan 15, 2025, 07:02 ET Regulatory Approval Clears Path for Oncolytics Biotech® to Advance Promising Pancreatic Cancer Treatment, Following a Review of Safety Data
has established itself both nationally and internationally. About Oncolytics Biotech Inc.Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized
More news about: Oncolytics Biotech® Inc.
Jan 15, 2025, 07:00 ET Alliance for Building Better Medicine Partners Secure $3.94 Million Federal Grant to Strengthen Richmond-Petersburg Region's Pharma and Biotech Workforce and Talent System
and industry leaders including Civica, Phlow, DCLS, and Haleon, will equip 228 individuals for good-paying technician-level jobs in the APM and biotechnology sectors. This initiative supports national priorities to reshore pharmaceutical manufacturing, strengthen the U.S. pharmaceutical supply
More news about: Alliance for Building Better Medicine
Jan 15, 2025, 04:00 ET Feed Additives Market worth $59.82 billion by 2029 - Exclusive Report by MarketsandMarkets™
that support animal health without using antimicrobials. The November 2022 study of the National Center for Biotechnology Information (NCBI) indicates a growing interest in natural feed additives as substitutes for antibiotics. These include
More news about: MarketsandMarkets
Jan 14, 2025, 21:39 ET Taiwan's Startup Hub in Silicon Valley Bridges U.S.-Taiwan Innovation Collaboration and Promotes Taiwan's Startups to the World
flexible supply chain, and continued investment in research and development of transformative technologies, including artificial intelligence, biotechnology, and green energy. These strengths are complemented by Silicon Valley's unrivaled innovative capabilities, creating a close partnership of synergy
More news about: Business Next Media Corp.
Jan 14, 2025, 20:48 ET SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Revance Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - RVNC
[Click here for information about joining the class action] Revance is a biotechnology company that develops, manufactures, and commercializes neuromodulators for various aesthetic and therapeutic indications in the
More news about: Pomerantz LLP